Theseus Pharmaceuticals, Inc.
THRX · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $118 | $408 | $376 | $193 |
| - Cash | $47 | $47 | $110 | $95 |
| + Debt | $4 | $4 | $4 | $4 |
| Enterprise Value | $75 | $364 | $270 | $102 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$16 | -$18 | -$17 | -$12 |
| % Margin | – | – | – | – |
| Net Income | -$14 | -$15 | -$12 | -$15 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.31 | -0.34 | -0.29 | -0.4 |
| % Growth | 8.8% | -17.2% | 27.5% | – |
| Operating Cash Flow | -$11 | -$10 | -$19 | -$10 |
| Capital Expenditures | -$0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$11 | -$10 | -$19 | -$10 |